Company news

Share this article:
Thomson Scientific, part of The Thomson Corporation, launched its Citation Impact Forum, an online forum promoting scholarly discussion about all facets of citation-based research evaluation. The Citation Impact Forum will feature interviews with and commentary from industry leaders - bibliometricians, researchers and publishers - about scholarly evaluation.  By becoming a registered member of the forum, users have the added ability to join invitation only forums where they can participate in discussions by sharing their own thoughts with other members.  Registered members can also recommend future forum discussion topics. Thomson Scientific will also use the Forum to address - or to clarify -- inaccuracies and common misinterpretations circulating among the scientific community, printed in journals, blogs and other forums.  Thomson Scientific's Citation Impact Forum, can be found by visiting: scientific.thomson.com/citationimpactforum/.

Bedford Laboratories, a division of Ben Venue Laboratories Inc., announced the acquisition of Cafcit (caffeine citrate) Injection and Cafcit (caffeine citrate) Oral Solution from Mead Johnson & Company. Bedford Laboratories is now the reference listed drug holder. Cafcit (caffeine citrate) is indicated for the short-term treatment of apnea in premature infants between 28 and <33 weeks gestational age. Ben Venue Laboratories is a subsidiary of Boehringer Ingelheim.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.